Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Keam Breast Cancer 2013 Oncology Response Criteria

Known as: KEAM BREAST CANCER 2013 
Clinical usefulness of AJCC response criteria for neoadjuvant chemotherapy in breast cancer. (Keam B, Im SA, Lim Y, Han SW, Moon HG, Oh DY, Cho N… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Introduction: Determining immunogenicity of tumors is important in predicting response to cancer immunotherapy. Tumor mutation… Expand
Is this relevant?
2019
2019
Purpose : Tumor microenvironment (TME) is a complex mixture of cells around tumor, showing different associations with tumor… Expand
Is this relevant?
2018
2018
Background: We aimed to compare intra- and extracranial responses to immune checkpoint inhibitors (ICIs) in lung cancer with… Expand
Is this relevant?
2017
2017
Background: Although EGFR exon 20 insertion mutation is the third most common among EGFR-mutant NSCLC, this mutant clones are… Expand
Is this relevant?
2017
2017
Background: To overcome immunosuppression, multiple pathways can be targeted by counter strategies, including elimination of… Expand
Is this relevant?
2015
2015
Background Oncogenic driver gene rearrangement involving RET proto-oncogene has been observed in about 1% of non-small-cell lung… Expand
Is this relevant?
2015
2015
Background: Programmed death-ligand 1 (PD-L1) expression is regarded as a predictive marker to anti-PD-1/ PD-L1 therapy. However… Expand
Is this relevant?
2015
2015
BACKGROUND Desmoid tumor (DT) is known as a locally aggressive tumor caused by altered Wnt/b-catenin signaling pathway. Although… Expand
Is this relevant?
2014
2014
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA Background: Despite the excellent initial responses of ALK… Expand
Is this relevant?